Cumberland Pharmaceuticals (CPIX) Other Accumulated Expenses (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Other Accumulated Expenses across 17 years of filings, most recently posting $13.0 million for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $13.0 million, up 15.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.0 million (up 15.67% YoY), and the FY2025 annual result was $12.6 million, up 3.14% from the prior year.
• Other Accumulated Expenses came in at $13.0 million for Q1 2026 at Cumberland Pharmaceuticals, up from $12.6 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $17.6 million in Q4 2022 to a low of $10.1 million in Q3 2025.
• The 5-year median for Other Accumulated Expenses is $13.0 million (2026), against an average of $13.1 million.
• Across the five-year window, Other Accumulated Expenses soared 102.9% in 2022 and decreased 24.51% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Other Accumulated Expenses stood at $17.6 million in 2022, then slipped by 22.69% to $13.6 million in 2023, then dropped by 9.9% to $12.3 million in 2024, then gained by 3.14% to $12.6 million in 2025, then gained by 2.72% to $13.0 million in 2026.
• The last three Other Accumulated Expenses figures came in at $13.0 million (Q1 2026), $12.6 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.